Randomized controlled trial of GemOx +/- R regimen in first-line treatment of elderly aggressive B cell lymphoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gemcitabine; Oxaliplatin; Rituximab
- Indications B-cell lymphoma
- Focus Adverse reactions; Therapeutic Use
- 15 Feb 2019 Biomarkers information updated
- 19 Aug 2012 Additional lead investigators added as reported by ClinicalTrials.gov record.
- 19 Aug 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01670370).